Prostate-Specific Antigen Testing in Untreated and Treated Prostatic Adenocarcinoma LESLIE M. RAINWATER, M.D., WILLIAM R. MORGAN, M.D. Mayo Clinic Proceedings Volume 65, Issue 8, Pages 1118-1126 (August 1990) DOI: 10.1016/S0025-6196(12)62725-6 Copyright © 1990 Mayo Foundation for Medical Education and Research Terms and Conditions
Fig. 1 Correlation of Mayo Clinic staging and Union Internationale Contrele Cancer (UICC) staging in cancer of the prostate. TNM = tumor, nodal involvement, distant metastatic involvement; TURP=transurethral resection of the prostate. (From Zincke H, Fleming TR, Furlow WL, Myers RP, Utz DC: Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate. Cancer 47:1901-1910, 1981. By permission of the American Cancer Society.) Mayo Clinic Proceedings 1990 65, 1118-1126DOI: (10.1016/S0025-6196(12)62725-6) Copyright © 1990 Mayo Foundation for Medical Education and Research Terms and Conditions
Fig. 2 Algorithm for approach to patient with normal or increased level of prostate-specific antigen (PSA). Bx = biopsy; US = ultrasonography. Mayo Clinic Proceedings 1990 65, 1118-1126DOI: (10.1016/S0025-6196(12)62725-6) Copyright © 1990 Mayo Foundation for Medical Education and Research Terms and Conditions